Pharmaids Pharmaceuticals Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported net loss was INR 61.62 million compared to net income of INR 0.089 million a year ago. Basic loss per share from continuing operations was INR 4.76 compared to basic earnings per share from continuing operations of INR 0.01 a year ago.
For the full year, net loss was INR 75.56 million compared to net income of INR 1.45 million a year ago. Basic loss per share from continuing operations was INR 5.86 compared to basic earnings per share from continuing operations of INR 0.14 a year ago.